Clinical Trial Update: A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety of the HIV-1 vaccine MVA-B in chronic HIV-1 infected patients successfully treated with HAART; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MVA-B

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | Phase 1 | Status: COMPLETED